CIK 0001314102
- Non-accelerated filer
- Smaller reporting company
EyePoint, Inc.
Sign in to watch- Ticker
- EYPT
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 262774444
- Phone
- +1 617-926-5000
- Business address
- 480 PLEASANT STREET, SUITE C400, WATERTOWN, MA, 02472
- Former names
- EyePoint Pharmaceuticals, Inc., pSivida Corp., pSivida LTD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-23 | ADAMIS ANTHONY P Director | Option exercise | +2,000 | 4,000 | ||
| 2024-06-23 | ADAMIS ANTHONY P Director | Option exercise · Restricted Stock Units | −2,000 | 2,000 | ||
| 2024-01-05 | ADAMIS ANTHONY P Director | Grant or award · Stock Option (Right to Buy) | +25,014 | 25,014 | ||
| 2023-06-23 | ADAMIS ANTHONY P Director | Option exercise | +2,000 | 2,000 | ||
| 2023-06-23 | ADAMIS ANTHONY P Director | Option exercise · Restricted Stock Units | −2,000 | 4,000 | ||
| 2023-06-20 | ADAMIS ANTHONY P Director | Grant or award · Stock Option (Right to Buy) | +26,100 | 26,100 | ||
| 2023-06-20 | ADAMIS ANTHONY P Director | Grant or award · Stock Option (Right to Buy) | +13,000 | 13,000 | ||
| 2022-06-23 | ADAMIS ANTHONY P Director | Grant or award · Restricted Stock Units | +6,000 | 6,000 | ||
| 2022-06-23 | ADAMIS ANTHONY P Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 |
Page 1 of 1 · 9 trades